- ROUNDTABLE: Pharmacy’s future in sync with technology
- Walgreens expanding scope of retail pharmacy experience and services heading into fiscal 2014
- Senate passes Drug Quality and Security Act
- EXPERT BLOG: Provider status for pharmacists — one way or another
- Study from NCPA sheds new light on med synchronization programs
PHOENIX — The University of Arizona Cancer Center, in partnership with Walgreens, last month opened a specialty outpatient pharmacy on-site to meet the needs of its patients.
Located on the first floor of the University of Arizona Cancer Center- North Campus, the Walgreens specialty pharmacy offers patients access to prescription medications in the same place they go for doctor’s visits and chemotherapy infusions. The approximately 800-sq.-ft. Walgreens pharmacy carries not only cancer medications but also all the regular medications a patient might be taking, making it a one-stop shop. Visitors to the pharmacy receive an electronic pager that vibrates and lights up when their prescription is ready. That way, patients have the option of staying in the pharmacy waiting area or heading down the hall to grab a cup of coffee or browse the cancer center’s boutique, Stumbo said.
The pharmacy helps the University of Arizona Cancer Center to meet its goal of providing comprehensive cancer care for its patients, stated Patti Stumbo, the center’s director of oncology services. “Being an [National Cancer Institute]-designated Comprehensive Cancer Center, we’re always on the lookout for what is the latest and the greatest and what our other centers doing for patient care,” Stumbo said. “Having a specialty pharmacy was beginning to crop up more and more.”
As a specialty oncology pharmacy, the Walgreens at the University of Arizona Cancer Center—North Campus offers cancer medications that may not be available at typical retail pharmacies. The pharmacy helps the cancer center prepare for the future of cancer care, in which prescription bottles might replace IVs for some cancer patients.
While chemotherapy infusions remain the most common cancer treatment, oral chemotherapy agents — in the forms of capsules, pills or liquids — are becoming increasingly available as an alternative to infusion therapies, and many new oral options are expected to go on the market in the next three to five years, noted Rafael Diaz, associate VP pharmacy and supply chain at the University of Arizona Medical Center—University Campus. “The new drugs in the pipeline are going to be oral, so that changes our business from an infusion business to an oral business,” he said.
Because the Walgreens pharmacists work right in the cancer center, they have easy access to physicians and to pharmacists from the center’s infusion pharmacy, where infusions are prepared, if questions about a patient’s treatment arise, Stumbo added.
The Walgreens pharmacy at the University of Arizona Cancer Center is one of about 10 Walgreens collaborations with academic medical centers across the United States. The Cancer Center decided to pursue the partnership after learning of successes of similar successful partnerships at academic medical facilities, such as the Ohio State University Hospital and Stanford Cancer Center, Diaz said.